🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The #FDA has granted approval to the kinase inhibitor #taletrectinib for the treatment of adults with locally advanced or metastatic ROS1-positive non–small cell #LungCancer (#NSCLC). Learn more about the #approval and the trials that led to it here: oncdata.com/taletrectinib-…

June is #NationalCancerSurvivorsMonth. Watch as Darcy Burbage, DNP, RN, AOCN, Oncology Clinical Nurse Specialist, shares advice for supporting #cancer #survivors and helping them navigate unique challenges throughout the #survivorship continuum. Watch here! youtu.be/gJOF1QnuLdY

This #PrideMonth, Oncology Data Advisor stands with the LGBTQ+ community in the fight against cancer. We're dedicated to providing the latest data and insights to address disparities in oncology care. 🏳️‍🌈 Your story matters. Your health matters. Happy Pride! #LGBTQHealth #Oncology

The #FDA has granted approval to #mitomycin intravesical solution for adult patients with recurrent low-grade intermediate-risk non–muscle invasive #BladderCancer (LG-IR-NMIBC). Learn more about the #approval and the #ENVISION trial here: oncdata.com/mitomycin-intr…

Happy #NursingAssistantsDay! Watch as Maria Badillo (Maria Badillo, MSN RN OCN CCRP) talks with her colleagues Erika Toledo and Kimberly Hartig-Balderas about their unique roles as nursing assistants in oncology care and research at MD Anderson Cancer Center. Watch here! youtu.be/ZV_RJSel32Q?si…

Happy #PrideMonth from OncData! In this video, Board members Lauren Ghazal, PhD, FNP-BC and Jasmin Hundal, M.D., DipABLM, M.S., M.P.H. share perspectives on #inclusive cancer care for #LGBTQ+ patients, including unique challenges and progress being made in ensuring equitable care for all. Watch here! youtu.be/Zxo-RDSjRzQ?si…

The #FDA has approved #pembrolizumab for use as a #perioperative treatment in adults with resectable locally advanced head and neck squamous cell #carcinoma (#HNSCC). This marks the first FDA #approval for HNSCC in 6 years! Learn more here: oncdata.com/pembrolizumab-…

In honor of #WorldKidneyCancerDay, Dr. David Maj shares his #ASCO25 presentation on the role of #IMDC prognostic factors in metastatic #renal cell carcinoma (#RCC) after first-line #immunotherapy and the implications for patient counseling. Watch here! youtu.be/m1IWA68DGsc?si…

Watch as Dr. Abigail Zamorano (Abigail S. Zamorano, MD MPHS) of McGovern Med School discusses her #ASCO25 poster highlighting the unique distress experienced by #caregivers of patients with #gynecologic cancers and what clinicians can do to help support caregivers. Watch here! youtube.com/watch?v=FTjF5V…

The #FDA has granted accelerated approval to #datopotamab deruxtecan-dlnk for locally advanced or metastatic EGFR-mutated non–small cell #LungCancer (#NSCLC). Learn more about the #approval and the #TROPION-Lung trials here: oncdata.com/datopotamab-de…

In this #ASCO25 video, Dr. Manali Patel of Stanford University discusses her team's presentation outlining the dangers that #NaturalDisasters pose to #cancer care and how health systems can develop comprehensive #emergency #preparedness plans. Watch here! youtu.be/_XAcbXwMrww ASCO

How does American Cancer Society use #AI to improve patient care? Watch as Waqas Haque speaks with Arif Kamal MD, MBA, MHS, Chief Patient Officer, about the intersection of #technology, patient #advocacy, and the future of cancer care. Watch here! youtu.be/RFisPwWFsIs?si… #AmericanCancerSociety

The #FDA has granted accelerated approval to #linvoseltamab-gcpt for the treatment of adults with relapsed or refractory multiple #myeloma. Learn more about the #approval and the #LINKERMM1 trial here: oncdata.com/linvoseltamab-…

Watch as Stephen Freedland, MD and Jun Gong of Cedars-Sinai explore the phase 3 #CHALLENGE trial, presented at #ASCO25, which showed encouraging results for the impact of a structured #exercise program on disease-free survival in #colon #cancer. Watch here! youtu.be/bIUmM2ZpwNk

The #FDA has granted accelerated approval to #sunvozertinib for adults with locally advanced or metastatic non–small cell #LungCancer (#NSCLC) harboring #EGFR exon 20 insertion mutations. Learn more about the #approval and the #WUKONG1B trial here: oncdata.com/sunvozertinib-…

On 7/17 and 8/5, Aman Chauhan is giving an i3 Health webinar exploring the diagnosis and treatment of #neuroendocrine tumors (#NETs). Here, he shares a preview of the exciting advances he'll be discussing. Watch here and learn how to register! youtu.be/EqFNE3qnTdo

#ASCO25 showcased #AI across the #oncology spectrum, from optimizing #prostate cancer therapy (ArteraAI) to streamlining research (#ASCOmind) to paving the way for targeted screening (Rambam Health Care Campus 🎗️ Technion Israel). Read Waqas Haque's thoughts here! oncdata.com/ai-at-asco/ ASCO

This #GlioblastomaAwarenessDay, Dr. Ajay Abad of Roswell Park highlights #SurVaxM, a novel survivin-targeted #vaccine for glioblastoma, and the importance of continued collaboration to move the needle forward in this aggressive disease. Watch here! youtu.be/DLuyFDSAd5Q

In honor of #SarcomaAwarenessMonth in July, Richard Riedel and Candace Haddox, MD share updates to their i3 Health Dedifferentiated #Liposarcoma (#DDLPS) Task Force. Watch here: youtu.be/ilcaR0lyms8?si… And view the full Task Force and position statement: i3health.com/course-informa…

In this Letter From the Editor, Rahul Banerjee, MD, FACP reflects on the groundbreaking findings of the CHALLENGE trial, which show that structured #exercise interventions can yield survival benefits rivaling those of established #cancer therapies. Read here! oncdata.com/letter-from-th…